{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:28:37Z","timestamp":1787761717971,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Oral submucous fibrosis (OSMF) in recent times has been recognized as a potentially malignant disorder (PMD) with an increased risk of developing oral squamous cell carcinoma with malignant transformation rates that vary from 0.6% to 36%. Alpha-L-fucosidase (AFU) is a lysosomal enzyme that is involved in maintaining the homeostasis of fucose metabolism. In benign and malignant tumors, the cells modulate their surface by increasing fucosylation leading to uncontrolled growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and objectives:<\/jats:title>\n                    <jats:p>This study was designed to estimate the levels of salivary and serum AFU in patients with OSMF and healthy controls and also to evaluate the clinical utility of salivary AFU levels over serum.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Saliva and blood samples were collected from twenty participants in both the groups (OSMF and healthy controls). Serum and salivary alpha-L-fucosidase levels were measured by enzyme-linked immunosorbent assay. The data were subjected to appropriate statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We found a significant increase in alpha-L-fucosidase level in OSMF compared with healthy subjects. Pearson's correlation showed salivary alpha-L-fucosidase level to have superior sensitivity in detecting OSMF compared with serum alpha-L-fucosidase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The outcome of this study suggests that salivary alpha-L-fucosidase can be utilized as a biomarker in early detection of oral precancer and cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jomfp.jomfp_225_21","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T05:21:36Z","timestamp":1682486496000},"page":"594","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Alpha-L-fucosidase levels in patients with oral submucous fibrosis and controls"],"prefix":"10.4103","volume":"26","author":[{"given":"H.","family":"Suresh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandhini","family":"Gunasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amritha","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Thayalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Ramesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-37-20240906","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"R2-37-20240906","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0022034511402082","article-title":"Global oral health inequalities in incidence and outcomes for oral cancer: Causes and solutions","volume":"23","author":"Johnson","year":"2011","journal-title":"Adv Dent Res"},{"key":"R3-37-20240906","doi-asserted-by":"crossref","first-page":"603740","DOI":"10.1155\/2011\/603740","article-title":"Understanding carcinogenesis for fighting oral cancer","volume":"2011","author":"Tanaka","year":"2011","journal-title":"J Oncol"},{"key":"R4-37-20240906","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3322\/canjclin.52.4.195","article-title":"Oral cancer and precancerous lesions","volume":"52","author":"Neville","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"R5-37-20240906","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/0378-6323.16229","article-title":"Epidemiological and clinicopathological study of oral leukoplakia","volume":"71","author":"Mishra","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R6-37-20240906","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12291-011-0149-8","article-title":"A review on salivary genomics and proteomics biomarkers in oral cancer","volume":"26","author":"Shah","year":"2011","journal-title":"Indian J Clin Biochem"},{"key":"R7-37-20240906","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12014-008-9017-9","article-title":"The potentials of glycolmics in biomarkerdiscovery","volume":"4","author":"Kam","year":"2008","journal-title":"Clin Proteome"},{"key":"R8-37-20240906","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/pr801057j","article-title":"The second golden age of glycomics: From functional glycomics to clinical applications","volume":"8","author":"Taniguchi","year":"2009","journal-title":"J Proteome Res"},{"key":"R9-37-20240906","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1373\/clinchem.2009.136333","article-title":"Sweetening the pot: Adding glycosylation to the biomarker discovery equation","volume":"56","author":"Drake","year":"2010","journal-title":"Clin Chem"},{"key":"R10-37-20240906","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0300-9084(03)00068-3","article-title":"Bioinformatics inglycobiology","volume":"85","author":"Marchan","year":"2003","journal-title":"Biochemie"},{"key":"R11-37-20240906","first-page":"292","article-title":"The emerging importanceof alpha-L-fucose in human breast cancer: A review","volume":"3","author":"Listinsky","year":"2011","journal-title":"Am J Transl Res"},{"key":"R12-37-20240906","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jcp.2009.071035","article-title":"Alterations in glycosylation as biomarkers for cancer detection","volume":"63","author":"Reis","year":"2010","journal-title":"J Clin Pathol"},{"key":"R13-37-20240906","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/0003-4819-115-8-623","article-title":"Clinical applications of serum tumor markers","volume":"115","author":"Bates","year":"1991","journal-title":"Ann Intern Med"},{"key":"R14-37-20240906","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.acthis.2010.02.004","article-title":"A glycobiology review: Carbohydrates, lectins and implications in cancer therapeutics","volume":"113","author":"Ghazarian","year":"2011","journal-title":"Acta Histochem"},{"key":"R15-37-20240906","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10719-007-9086-4","article-title":"Tissue and serum alpha 2-3-and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis","volume":"25","author":"Shah","year":"2008","journal-title":"Glycoconj J"},{"key":"R16-37-20240906","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ijc.28754","article-title":"Potentially malignant disorders of the oral cavity: Current practice and future directions in the clinic and laboratory","volume":"136","author":"Dionne","year":"2015","journal-title":"Int J Cancer"},{"key":"R17-37-20240906","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4172\/2157-2518.1000108","article-title":"Oral submucous fibrosis: A clinico-histopathological comparative study in population of southern Rajasthan","volume":"1","author":"Goel","year":"2010","journal-title":"J Carcinogene Mutagene"},{"key":"R18-37-20240906","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.oooo.2015.11.024","article-title":"Malignant transformation of oral submucous fibrosis: Overview of histopathological aspects","volume":"122","author":"Ray","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R19-37-20240906","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/1097-0142(19920901)70:5<1044::AID-CNCR2820700506>3.0.CO;2-U","article-title":"Serum alpha-L-fucosidase. A useful marker in the diagnosis of hepatocellular carcinoma","volume":"70","author":"Giardina","year":"1992","journal-title":"Cancer"},{"key":"R20-37-20240906","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.oooo.2013.01.004","article-title":"Evaluation of serum and salivary total sialic acid and \u03b1-l-fucosidase in patients with oral precancerous conditions and oral cancer","volume":"115","author":"Vajaria","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R21-37-20240906","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/cncr.23556","article-title":"Serum fucosylation changes in oral cancer and oral precancerous conditions: Alpha-L-fucosidase as a marker","volume":"113","author":"Shah","year":"2008","journal-title":"Cancer"},{"key":"R22-37-20240906","first-page":"2709","article-title":"Estimation of L-fucose and sialic acid as prognostic markers in precancerous condition in Mangalore population","volume":"7","author":"Poojary","year":"2016","journal-title":"Research Journal of Pharmaceutical, Biological and Chemical Sciences"},{"key":"R23-37-20240906","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.7314\/APJCP.2015.16.17.7497","article-title":"Comparison of serum fucose levels in leukoplakia and oral cancer patients","volume":"16","author":"Rai","year":"2015","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Journal of Oral and Maxillofacial Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_225_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:03:46Z","timestamp":1787760226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_225_21"}},"subtitle":["A comparative study"],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jomfp.jomfp_225_21","relation":{},"ISSN":["0973-029X"],"issn-type":[{"value":"0973-029X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}